000			02092 a2200589 4500
005			20250513222739.0
264		0	_c20001121
008			200011s 0 0 eng d
022			_a1524-4563
024	7		_a10.1161/01.hyp.36.4.561 _2doi
040			_aNLM _beng _cNLM
100	1		_aCao, Z
245	0	0	_aBlockade of the renin-angiotensin and endothelin systems on progressive renal injury. _h[electronic resource]
260			_bHypertension (Dallas, Tex. : 1979) _cOct 2000
300			_a561-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiotensin Receptor Antagonists
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAntihypertensive Agents _xadministration & dosage
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCollagen _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEndothelin Receptor Antagonists
650	0	4	_aEndothelin-1 _xmetabolism
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aKidney _xdrug effects
650	0	4	_aMale
650	0	4	_aNephrectomy
650	0	4	_aProteinuria _xurine
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptor, Angiotensin, Type 1
650	0	4	_aReceptor, Angiotensin, Type 2
650	0	4	_aReceptor, Endothelin A
650	0	4	_aReceptor, Endothelin B
650	0	4	_aRenal Insufficiency _xdrug therapy
650	0	4	_aRenin-Angiotensin System _xdrug effects
650	0	4	_aSeverity of Illness Index
650	0	4	_aTransforming Growth Factor beta _xgenetics
700	1		_aCooper, M E
700	1		_aWu, L L
700	1		_aCox, A J
700	1		_aJandeleit-Dahm, K
700	1		_aKelly, D J
700	1		_aGilbert, R E
773	0		_tHypertension (Dallas, Tex. : 1979) _gvol. 36 _gno. 4 _gp. 561-8
856	4	0	_uhttps://doi.org/10.1161/01.hyp.36.4.561 _zAvailable from publisher's website
999			_c10985249 _d10985249